header
Image from OpenLibrary

Molecular basis of influenza a virus sensitivity to commercial drugs : Screening for novel antiviral compounds / Ola Muhamed Mansour Fathy Abdalla ; Supervised Hamdi Mahmoud Hassaneen , Mohammed Ahmed Ahmed Ali

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Ola Muhamed Mansour Fathy Abdalla , 2016Description: 119 P. : photographs ; 25cmOther title:
  • الأسس الجزيئية لحساسية فيروسات الأنفلونزا إيه للعقاقير المتداولة : البحث عن مضادات فيروسات جديدة [Added title page title]
Subject(s): Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (M.Sc.) - Cairo University - Faculty of Science - Department of Biotechnology Summary: In Egypt, highly pathogenic avian influenza subtype H5NI virus (HPAIV/H5NI) was first reported in poultry in mid-february 2006 and declared to be endemic in 2008. The inadequate control measures enabled H5NI viruses to spread. Genetic drift in the virus was observed continuously each year and became more intense after 2008. Therefore, there is a necessity to develop new antiviral drugs targeting and eliminating the role of essential viral and cellular elements in the life cycle of the virus. The availability of drugs of different mode of actions would improve drug combination therapies to avoid the rapid emergence of drug-resistant viral strains. Despite, the re-emergence of amantadine-resistant HPAI H5NI and available reports about limited oseltamivir-resistant HPAI H5NI in Egypt which are based on theoretical sequence analysis of drug resistance markers, experimental studies to confirm the theoretical susceptibility of HPAI H5NI viruses to amantadine and oseltamivir are currently rare in Egypt
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Date due Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.12.25.M.Sc.2016.Ol.M (Browse shelf(Opens below)) Not for loan 01010110071949000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.12.25.M.Sc.2016.Ol.M (Browse shelf(Opens below)) 71949.CD Not for loan 01020110071949000

Thesis (M.Sc.) - Cairo University - Faculty of Science - Department of Biotechnology

In Egypt, highly pathogenic avian influenza subtype H5NI virus (HPAIV/H5NI) was first reported in poultry in mid-february 2006 and declared to be endemic in 2008. The inadequate control measures enabled H5NI viruses to spread. Genetic drift in the virus was observed continuously each year and became more intense after 2008. Therefore, there is a necessity to develop new antiviral drugs targeting and eliminating the role of essential viral and cellular elements in the life cycle of the virus. The availability of drugs of different mode of actions would improve drug combination therapies to avoid the rapid emergence of drug-resistant viral strains. Despite, the re-emergence of amantadine-resistant HPAI H5NI and available reports about limited oseltamivir-resistant HPAI H5NI in Egypt which are based on theoretical sequence analysis of drug resistance markers, experimental studies to confirm the theoretical susceptibility of HPAI H5NI viruses to amantadine and oseltamivir are currently rare in Egypt

Issued also as CD

There are no comments on this title.

to post a comment.